Mohamedali KA - Search Results

1

Probing the functional role of two conserved active site aspartates in mouse adenosine deaminase.

Sideraki V, Mohamedali KA, Wilson DK, Chang Z, Kellems RE, Quiocho FA, Rudolph FB. Sideraki V, et al. Among authors: mohamedali ka. Biochemistry. 1996 Jun 18;35(24):7862-72. doi: 10.1021/bi952920d. Biochemistry. 1996. PMID: 8672487

2

Site-directed mutagenesis of active site glutamate-217 in mouse adenosine deaminase.

Mohamedali KA, Kurz LC, Rudolph FB. Mohamedali KA, et al. Biochemistry. 1996 Feb 6;35(5):1672-80. doi: 10.1021/bi9514119. Biochemistry. 1996. PMID: 8634299

3

The highest levels of purine catabolic enzymes in mice are present in the proximal small intestine.

Mohamedali KA, Guicherit OM, Kellems RE, Rudolph FB. Mohamedali KA, et al. J Biol Chem. 1993 Nov 5;268(31):23728-33. J Biol Chem. 1993. PMID: 8226898 Free article.

4

The glycine box: a determinant of specificity for fibroblast growth factor.

Luo Y, Lu W, Mohamedali KA, Jang JH, Jones RB, Gabriel JL, Kan M, McKeehan WL. Luo Y, et al. Among authors: mohamedali ka. Biochemistry. 1998 Nov 24;37(47):16506-15. doi: 10.1021/bi9816599. Biochemistry. 1998. PMID: 9843417

5

Common and specific determinants for fibroblast growth factors in the ectodomain of the receptor kinase complex.

Wang F, Lu W, McKeehan K, Mohamedali K, Gabriel JL, Kan M, McKeehan WL. Wang F, et al. Biochemistry. 1999 Jan 5;38(1):160-71. doi: 10.1021/bi981758m. Biochemistry. 1999. PMID: 9890894

6

Overexpression of biologically active VEGF121 fusion proteins in Escherichia coli.

Kim S, Mohamedali KA, Cheung LH, Rosenblum MG. Kim S, et al. Among authors: mohamedali ka. J Biotechnol. 2007 Feb 20;128(3):638-47. doi: 10.1016/j.jbiotec.2006.11.027. Epub 2006 Dec 12. J Biotechnol. 2007. PMID: 17218033

7

Inhibition of prostate tumor growth and bone remodeling by the vascular targeting agent VEGF121/rGel.

Mohamedali KA, Poblenz AT, Sikes CR, Navone NM, Thorpe PE, Darnay BG, Rosenblum MG. Mohamedali KA, et al. Cancer Res. 2006 Nov 15;66(22):10919-28. doi: 10.1158/0008-5472.CAN-06-0459. Cancer Res. 2006. PMID: 17108129

8

The vascular-targeting fusion toxin VEGF121/rGel inhibits the growth of orthotopic human bladder carcinoma tumors.

Mohamedali KA, Kedar D, Sweeney P, Kamat A, Davis DW, Eve BY, Huang S, Thorpe PE, Dinney CP, Rosenblum MG. Mohamedali KA, et al. Neoplasia. 2005 Oct;7(10):912-20. doi: 10.1593/neo.05292. Neoplasia. 2005. PMID: 16242074 Free PMC article.

9

The functionalized human serine protease granzyme B/VEGF₁₂₁ targets tumor vasculature and ablates tumor growth.

Mohamedali KA, Cao Y, Cheung LH, Hittelman WN, Rosenblum MG. Mohamedali KA, et al. Mol Cancer Ther. 2013 Oct;12(10):2055-66. doi: 10.1158/1535-7163.MCT-13-0165. Epub 2013 Jul 15. Mol Cancer Ther. 2013. PMID: 23858102 Free PMC article.

10

Inhibition of prostate cancer osteoblastic progression with VEGF121/rGel, a single agent targeting osteoblasts, osteoclasts, and tumor neovasculature.

Mohamedali KA, Li ZG, Starbuck MW, Wan X, Yang J, Kim S, Zhang W, Rosenblum MG, Navone NM. Mohamedali KA, et al. Clin Cancer Res. 2011 Apr 15;17(8):2328-38. doi: 10.1158/1078-0432.CCR-10-2943. Epub 2011 Feb 22. Clin Cancer Res. 2011. PMID: 21343372 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32 results

Search Page

Filters